- freely available
Int. J. Mol. Sci. 2014, 15(5), 7594-7610; doi:10.3390/ijms15057594
Published: 5 May 2014
Abstract: Post-translational modifications (PTMs) play crucial roles in various cell functions and biological processes. Protein hydroxylation is one type of PTM that usually occurs at the sites of proline and lysine. Given an uncharacterized protein sequence, which site of its Pro (or Lys) can be hydroxylated and which site cannot? This is a challenging problem, not only for in-depth understanding of the hydroxylation mechanism, but also for drug development, because protein hydroxylation is closely relevant to major diseases, such as stomach and lung cancers. With the avalanche of protein sequences generated in the post-genomic age, it is highly desired to develop computational methods to address this problem. In view of this, a new predictor called “iHyd-PseAAC” (identify hydroxylation by pseudo amino acid composition) was proposed by incorporating the dipeptide position-specific propensity into the general form of pseudo amino acid composition. It was demonstrated by rigorous cross-validation tests on stringent benchmark datasets that the new predictor is quite promising and may become a useful high throughput tool in this area. A user-friendly web-server for iHyd-PseAAC is accessible at http://app.aporc.org/iHyd-PseAAC/. Furthermore, for the convenience of the majority of experimental scientists, a step-by-step guide on how to use the web-server is given. Users can easily obtain their desired results by following these steps without the need of understanding the complicated mathematical equations presented in this paper just for its integrity.
Most proteins perform their functions after post-translational modifications (PTMs). Protein hydroxylation is one type of PTM that involves the conversion of a CH group into a COH group (Figure 1) and is closely relevant to the regulation of the transcription factor (hypoxia-inducible factor) . Both the proline and lysine residues in proteins can be hydroxylated, forming hydroxyproline (Figure 1a) or HyP and hydroxylysine (Figure 1b) or HyL, respectively. However, the former is more common than the latter [2,3]. Furthermore, HyP is the key factor in stabilizing collagens [4,5], whose instability or abnormal activity may cause stomach cancer  and lung cancer [7,8]. Therefore, identifying the HyP and HyL sites in proteins may provide useful information for both biomedical research and drug development.
Identification of hydroxylation residues with experiments was mainly done by means of mass spectrometry [1,9], which was expensive and laborious. Facing the avalanche of protein sequences generated in the post genomic age, it is highly demanded to develop a computational method for timely and effectively identifying the hydroxylation residues in proteins. However, to our best knowledge, so far, only two papers have been published in this regard [10,11]. Additionally, further development in this important area is definitely needed for the following reasons. First, with a rapidly growing database in protein hydroxylation, the benchmark datasets used in the two methods definitely need to be updated; Second, some sequence order effects were missed, which would certainly affect their prediction quality; Third, none of them provided a publicly accessible web-server, and hence, their practical usage value is substantially limited.
The present study was devoted to develop a new predictor for identifying hydroxyproline and hydroxylysine in proteins by considering the above three aspects. The principle was based on a window sliding strategy, quite similar to the popular approach developed by Garnier and Robson  for predicting the secondary structure of globular proteins.
As demonstrated by a series of recent publications [13–20] and summarized in a comprehensive review , to develop a really useful predictor for a protein or peptide system, we need to go through the following five steps: (1) select or construct a valid benchmark dataset to train and test the predictor; (2) represent the protein or peptide samples with an effective formulation that can truly reflect their intrinsic correlation with the target to be predicted; (3) introduce or develop a powerful algorithm or operation engine to conduct the prediction; (4) properly perform cross-validation tests to objectively evaluate the anticipated prediction accuracy; (5) establish a user-friendly web-server for the predictor that is accessible to the public. Below, let us elaborate on how to deal with these five steps.
2. Results and Discussion
2.1. Benchmark Dataset
In this study, the benchmark dataset was derived from dbPTM 3.0  at http://dbptm.mbc.nctu.edu.tw/, a protein post-translational modifications database. For facilitating the description later, let us adopt Chou’s peptide formulation, which was used for investigating the HIV protease cleavage sites [23,24], the specificity of GalNAc-transferase , as well as signal peptide cleavage sites [26–29]. According to Chou’s scheme, a peptide with Pro (namely P in its single-letter code) or Lys (namely K) located at its center (Figure 2) can be expressed as:
where the subscript, ξ, is an integer (cf. Figure 2), R−ξ represents the ξ-th downstream amino acid residue from the center, Rξ the ξ-th upstream amino acid residue, and so forth. Peptides P(ℙ) and P( ) with the profile of Equation (1) can be further classified into the following categories:
where ∈ represents “a member of” in the set theory.
As pointed out by a comprehensive review , there is no need to separate a benchmark dataset into a training dataset and a testing dataset for examining the performance of a prediction method if it is tested by the jackknife test or subsampling cross-validation test. Thus, the benchmark dataset for the current study can be formulated as:
where is the benchmark dataset for studying hydroxyproline residues, the benchmark dataset for studying hydroxylysine residues, ⋃ the symbol for “union” in the set theory, contains the samples for the Pro-hydroxylated peptide only, contains the non-Pro-hydroxylated peptide only (cf. Equation (2)), contains the samples for the Lys-hydroxylated peptide only and contains the non-Lys-hydroxylated peptide only (cf. Equation (3)).
After some preliminary trials, we found that ξ = 6 was a good choice for the current study. Accordingly, each of the samples extracted from proteins in this study is actually a 2ξ +1 = 13 tuple peptide. If the upstream or downstream in a peptide sample was 3≤ ξ < 6, the lacking residues were filled with the dummy code, @. Furthermore, to reduce the redundancy and to avoid homology bias, those peptides were excluded from the benchmark datasets that had ≥ 80% pairwise sequence identity to any other in a same subset.
Finally, we obtained that the benchmark dataset, , contained 636 + 2699 = 3338 peptide samples, of which 636 were Pro-hydroxylated peptides belonging the positive subset , and 2669 were non-Pro-hydroxylated peptides belonging to the negative subset, ; and that the benchmark dataset, , contained 107 + 836 = 943 peptide samples, of which 107 were Lys-hydroxylated peptides belonging to the positive subset, , and 836 were non-Lys-hydroxylated peptides belonging to the negative subset, . For the reader’s convenience, the peptide sequences, as well as their hydroxylation or non-hydroxylation sites in proteins are given in the Supplementary Information, S1 and S2, for and , respectively.
2.2. Feature Vector Construction
To develop a statistical method for predicting the attribute of peptides in proteins, one of the fundamental procedures was to formulate the peptide samples with an effective mathematical expression that could really reflect the intrinsic correlation with the desired target. To realize this, various feature vectors (see, e.g., [17,31–36]) were proposed to express peptides by extracting their different features into the pseudo amino acid composition [37,38] or Chou’s pseudo amino acid composition [39–41] or Chou’s PseAAC (pseudo amino acid composition) [42,43].
According to , the general form of PseAAC for a protein or peptide, P, can be formulated by:
where T is the transpose operator, while Ω is an integer to reflect the vector’s dimension. The value of Ω, as well as the components ψu (u = 1, 2, ···, Ω) in Equation (5) will depend on how to extract the desired information from the protein or peptide sequence. Below, let us describe how to extract the useful information from the benchmark datasets, and , to define the peptide samples via Equation (5).
Since each of the samples concerned is a 13-tuple peptide, Equation (1) can be simplified to a more convenient form given by:
where R7 = P or K, and Ri (i = 1, 2, ··· , 13; i ≠ 7) can be any of the 20 native amino acids or the dummy code @, as defined above. Hereafter, let us use the numerical codes 1, 2, 3, ···, 20 to represent the 20 native amino acids according to the alphabetic order of their single letter codes and use 21 to represent the dummy amino acid, @. Accordingly, the number of possible different dipeptides will be 21 × 21 = 441, and the number of dipeptide subsite positions on the sequence of Equation (6) will be (13 − 2 + 1) = 12.
where the element:
In Equation (5)F+ (Di | j) is the occurrence frequency of the i-th dipeptide (i = 1,2, ···, 441) at the j-th subsite on the sequence of Equation (6) that can be easily derived from the positive dataset in the Supplementary Information S1 or S2; while F− (Di | j) is the corresponding occurrence frequency, but derived from the negative dataset.
2.3. Prediction Algorithm
Suppose ℙ+ are the standard vectors or norms for the peptide sequences in the positive benchmark dataset, or , and ℙ− are those in the negative benchmark dataset, or . Additionally, they are defined by:
where N+ is the total number of Pro-hydroxylated peptides or Lys- hydroxylated peptides in the benchmark dataset, or , and the u-th component for the k-th Pro-hydroxylated peptide or Lys-hydroxylated peptide in the PseAAC space (see Equations (5) and (10)); whereas N− and have the same meanings, but are for the K-th non-Pro-hydroxylated peptide or non-Lys-hydroxylated peptide.
For a query peptide, P, as formulated by Equation (5), suppose (P, ℙ+) is its similarity to the norm of hydroxylated peptides and (P, ℙ−) its similarity to the norm of non-hydroxylated peptides, as formulated by:
If there was a tie between (P, ℙ+) and (P, ℙ−), the query peptide would be randomly assigned between the hydroxylated peptide and non-hydroxylated peptide categories. However, this kind of tie case rarely happened and actually never happened in our study.
The predictor established via the above procedures is called iHyd-PseAAC, where “i” stands for the first character of “identify”, “Hyd” for “hydroxylation” and “PseAAC” for the general form of the pseudo amino acid composition  used to formulate the peptide sequences.
A flowchart of the predictor is given in Figure 3 to illustrate how iHyd-PseAAC was working during the process of prediction.
3. Experimental Section
3.1. A Set of Metrics for Measuring Prediction Quality
To provide a more intuitive and easier-to-understand method to measure the prediction quality, the following set of four metrics based on the formulation used by Chou [26–28] in predicting signal peptides was adopted. According to Chou’s formulation, the sensitivity, specificity, overall accuracy, and Matthews correlation coefficient can be respectively expressed as [18,33,36,45]:
where N+ is the total number of the hydroxylated Pro-peptides (or Lys-peptides) investigated, while is the number of hydroxylated Pro-peptides (or Lys-peptides) incorrectly predicted as the non-hydroxylated Pro-peptides (or Lys-peptides); N− is the total number of the non-hydroxylated Pro-peptides (or Lys-peptides) investigated, while is the number of the non-hydroxylated Pro-peptides (or Lys-peptides) incorrectly predicted as the hydroxylated Pro-peptides (or Lys-peptides).
According to Equation (15), we can easily see the following. When , meaning none of the hydroxylated Pro-peptides (or Lys-peptides) was mispredicted to be a non-hydroxylated Pro-peptide (or Lys-peptides), we have the sensitivity Sn = 1; while , meaning that all the hydroxylated Pro-peptides (or Lys-peptides) were mispredicted to be the non-hydroxylated Pro-peptides (or Lys-peptides), we have the sensitivity Sn = 0. Likewise, when , meaning none of the non-hydroxylated Pro-peptides (or Lys-peptides) was mispredicted, we have the specificity Sn = 1; while , meaning all the non-hydroxylated Pro-peptides (or Lys-peptides) were incorrectly predicted as hydroxylated Pro-peptides (or Lys-peptides), we have the specificity Sn = 0. When , meaning that none of the hydroxylated Pro-peptides (or Lys-peptides) in the dataset (or ) and none of the hydroxylated Pro-peptides (or Lys-peptides) in (or ) was incorrectly predicted, we have the overall accuracy Acc = 1; while and , meaning that all the hydroxylated Pro-peptides (or Lys-peptides) in the dataset (or ) and all the non-hydroxylated Pro-peptides (or Lys-peptides) in (or ) were mispredicted, we have the overall accuracy Acc = 0. The Matthews correlation coefficient (MCC) is usually used for measuring the quality of binary (two-class) classifications. When , meaning that none of the hydroxylated Pro-peptides (or Lys-peptides) in the dataset (or ) and none of the non-hydroxylated Pro-peptides (or Lys-peptides) in (or ) was mispredicted, we have MCC = 1; when and , we have MCC = 0, meaning no better than random prediction; when and , we have MCC = 0, meaning total disagreement between prediction and observation. As we can see from the above discussion, it is much more intuitive and easier-to-understand when using Equation (15) to examine a predictor for its four metrics, particularly for its Mathew’s correlation coefficient. It is instructive to point out that the metrics as defined in Equation (15) are valid for single-label systems; for multi-label systems [34,46–48], a set of more complicated metrics should be used, as given in .
3.2. Jackknife Cross-Validation
How to properly test a predictor for its anticipated success rates is very important in objectively evaluating its quality and potential application value. Generally speaking, the following three cross-validation methods are often used to examine the quality of a predictor and its effectiveness in practical application: the independent dataset test, the subsampling or the K-fold (such as 5-, 7- or 10-fold) crossover test and the jackknife test . However, as elaborated by a penetrating analysis in , considerable arbitrariness exists in the independent dataset test. Furthermore, as demonstrated in , the subsampling (or K-fold crossover validation) test cannot avoid arbitrariness either. The jackknife test is the least arbitrary, which can always yield a unique result for a given benchmark dataset. Therefore, the jackknife test has been widely recognized and increasingly utilized by investigators to examine the quality of various predictors (see, e.g., [32,53–62]). Accordingly, in this study, the jackknife test was also adopted to evaluate the accuracy of the current predictor. Listed in Table 1 are the jackknife test results obtained by iHyd-PseAAC on the benchmark datasets of Supplementary Information S1 and the benchmark dataset of Supplementary Information S2, respectively.
To further demonstrate our predictor, the jackknife test was conducted on two more stringent benchmark datasets given in Supplementary Information S3 and S4, where none of the included sequences has more than 40% pairwise sequence identity with any other. The results thus obtained are listed in Table 2.
It is interesting to see by comparing the two tables that the rates of Acc and MCC are about the same in both cases. Although the rates of Sn in Table 2 are somewhat lower than those in Table 1, the rates of Sp in Table 2 are higher than those in Table 1. Accordingly, the success rates as measured by the four metrics in Equation (15) are basically about the same without dropping down significantly from using an 80% cutoff benchmark dataset to a 40% cutoff one, clearly indicating that iHyd-PseAAC is a useful predictor validated by rigorous cross-validation.
3.3. Test by Public Database
Moreover, from the Swiss-Prot database, we retrieved all those proteins whose hydroxylated sites were experimentally validated. After excluding those with a length less than 50 amino acids, we obtained 156 hydroxyproline proteins and 31 hydroxylysine proteins, respectively. Their codes and hydroxylated sites are given in Supplementary Information S5 and S6, respectively. The predicted results by iHyd-PseAAC on these real proteins are given in Table 3, from which we can see that the overall success rates thus obtained are quite consistent with those derived by the cross-validation on the benchmark datasets, as shown in Tables 1 and 2, fully indicating that iHyd-PseAAC is not only a valid predictor, but also may become a very useful high throughput toll for practical applications in this area.
As we can see from Table 1, the overall accuracies for the hydroxyproline and hydroxylysine cases are 80.57% and 83.56%, which are higher than 76.0% and 82.1%, the corresponding rates reported by Hu et al. . At first glance, the value of MCC seems relatively low. Actually, as mentioned in Section 3.1, different from Acc, whose score is between 100% and 0%, the score for MCC is between one and −1, with zero meaning no better than random prediction. Accordingly, the MCC rate of 0.50–0.51 is generally deemed as a quite decent result. Particularly, the benchmark dataset in the current system is very imbalanced, which contains 636 hydroxylated peptides and 2669 non-hydroxylated peptides for proline, which also may lower the MCC rate. The same is true for the case of hydroxylation.
Particularly, no web-server was provided for the method in , and hence, its application value is quite limited. Actually, so far, no web-server whatsoever has been provided in this area. As pointed out in  and emphasized in a series of recent publications (see, e.g., [16–18,20,42,45]), one of the keys in developing a practically more useful prediction method is to establish a user-friendly and publicly accessible web-server. In view of this, the web-server for iHyd-PseAAC has been established, which can be freely accessed at http://app.aporc.org/iHyd-PseAAC/.
Furthermore, for the convenience of the vast majority of biologists and pharmaceutical scientists, below, let us provide a step-by-step guide to show how the users can easily get the desired result by using iHyd-PseAAC without the need to follow the complicated mathematical equations presented in this paper just for its integrity.
5. The User Guide for the Web-Server iHyd-PseAAC
Step 1. Open the web-server at the site at http://app.aporc.org/iHyd-PseAAC/, and you will see the top page of the predictor on your computer screen, as shown in Figure 4. Click on the “Read Me” button to see a brief introduction about the iHyd-PseAAC predictor and the caveat when using it.
Step 2. Either type or copy/paste the query protein sequences into the input box at the center of Figure 4. The protein sequences should be in FASTA format. The input examples can be seen by clicking on the “Example” button right above the input box.
Step 4. Click on the “Citation” button to find the relevant paper that documents the detailed development and algorithm of iHyd-PseAAC.
Step 5. Click on the “Data” button to download the benchmark dataset used to train and test the iHyd-PseAAC predictor.
Supplementary Information S1. The positive dataset, , and negative dataset, , contain 636 hydroxyproline peptide fragments and 2699 non-hydroxyproline peptide fragments, respectively. None of the sequences included has ≥ 80% pairwise sequence identity with any other in the same subset.
Supplementary Information S2. The positive dataset, , and negative dataset, , contain 107 hydroxylysine peptide fragments and 836 non-hydroxylysine peptide fragments, respectively. None of the sequences included has ≥ 80% pairwise sequence identity with any other in the same subset.
Supplementary Information S3. The positive dataset, , and negative dataset, , contain 306 hydroxyproline peptide fragments and 1035 non-hydroxyproline peptide fragments, respectively. None of the sequences included has ≥ 40% pairwise sequence identity with any other in the same subset.
Supplementary Information S4. The positive dataset, , contains 44 hydroxylysine peptide fragments, and the negative dataset, , contains 528 non-hydroxylysine peptide fragments. None of the sequences included has ≥ 40% pairwise sequence identity with any other in the same subset.
Supplementary Information S5. The 156 experimentally validated hydroxyproline proteins and their hydroxylated sites were retrieved from the Swiss-Prot database.
Supplementary Information S6. The 31 experimentally validated hydroxylysine proteins and their hydroxylated sites were retrieved from the Swiss-Prot database.
The authors wish to thank the three anonymous reviewers for their constructive comments, which were very helpful in strengthening the presentation of this study. This work is supported by the National Natural Science Foundation of China (No. 11301024, No. 11371365, No. 11101029, No. 31201002, No. 11071013) and the Fundamental Research Funds for the Central Universities.
Conflicts of Interest
The authors declare no conflict of interest.
- Author ContributionsXu and Chou conceived and designed the experiments. Wen and Shao processed and analyzed data. Xu and Deng wrote the manuscript.
- Cockman, M.E.; Webb, J.D.; Kramer, H.B.; Kessler, B.M.; Ratcliffe, P.J. Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Mol. Cell Proteomics 2009, 8, 535–546.
- Yamauchi, M.; Shiiba, M. Lysine hydroxylation and cross-linking of collagen. Methods Mol. Biol 2008, 446, 95–108.
- Chopra, R.K.; Ananthanarayanan, V.S. Conformational implications of enzymatic proline hydroxylation in collagen. Proc. Natl. Acad. Sci. USA 1982, 79, 7180–7184.
- Krane, S.M. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 2008, 35, 703–710.
- Palfi, V.K.; Perczel, A. How stable is a collagen triple helix? An ab initio study on various collagen and beta-sheet forming sequences. J. Comput. Chem 2008, 29, 1374–1386.
- Guszczyn, T.; Sobolewski, K. Deregulation of collagen metabolism in human stomach cancer. Pathobiology 2004, 71, 308–313.
- Sunila, E.S.; Kuttan, G. A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol. Immunotoxicol 2006, 28, 269–280.
- Guruvayoorappan, C.; Kuttan, G. Anti-metastatic effect of Biophytum sensitivum is exerted through its cytokine and immunomodulatory activity and its regulatory effect on the activation and nuclear translocation of transcription factors in B16F-10 melanoma cells. J. Exp. Ther. Oncol 2008, 7, 49–63.
- Richards, A.A.; Stephens, T.; Charlton, H.K.; Jones, A.; Macdonald, G.A.; Prins, J.B.; Whitehead, J.P. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: Evidence for regulation of multimerization by alterations in posttranslational modifications. Mol. Endocrinol 2006, 20, 1673–1687.
- Yang, Z.R. Predict collagen hydroxyproline sites using support vector machines. J. Comput. Biol 2009, 16, 691–702.
- Hu, L.L.; Niu, S.; Huang, T.; Wang, K.; Shi, X.H.; Cai, Y.D. Prediction and analysis of protein hydroxyproline and hydroxylysine. PLoS One 2010, 5, e15917.
- Garnier, J.; Osguthorpe, D.J.; Robson, B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol 1978, 120, 97–120.
- Guo, S.H.; Deng, E.Z.; Xu, L.Q.; Ding, H.; Lin, H.; Chen, W.; Chou, K.C. iNuc-PseKNC: A sequence-based predictor for predicting nucleosome positioning in genomes with pseudo k-tuple nucleotide composition. Bioinformatics 2014, doi:10.1093/bioinformatics/btu083.
- Liu, B.; Zhang, D.; Xu, R.; Xu, J.; Wang, X.; Chen, Q.; Dong, Q.; Chou, K.C. Combining evolutionary information extracted from frequency profiles with sequence-based kernels for protein remote homology detection. Bioinformatics 2014, 30, 472–479.
- Fan, Y.N.; Xiao, X.; Min, J.L.; Chou, K.C. iNR-Drug: Predicting the interaction of drugs with nuclear receptors in cellular networking. Int. J. Mol. Sci 2014, 15, 4915–4937.
- Qiu, W.R.; Xiao, X.; Chou, K.C. iRSpot-TNCPseAAC: Identify recombination spots with trinucleotide composition and pseudo amino acid components. Int. J. Mol. Sci 2014, 15, 1746–1766.
- Min, J.L.; Xiao, X.; Chou, K.C. iEzy-Drug: A web server for identifying the interaction between enzymes and drugs in cellular networking. BioMed Res. Int 2013, 2013, 701317, doi:10.1155/2013/701317.
- Chen, W.; Feng, P. M.; Lin, H.; Chou, K.C. iRSpot-PseDNC: Identify recombination spots with pseudo dinucleotide composition. Nucleic Acids Res 2013, 41, e69.
- Feng, P.M.; Chen, W.; Lin, H.; Chou, K.C. iHSP-PseRAAAC: Identifying the heat shock protein families using pseudo reduced amino acid alphabet composition. Anal. Biochem 2013, 442, 118–125.
- Xiao, X.; Min, J.L.; Wang, P.; Chou, K.C. iCDI-PseFpt: Identify the channel-drug interaction in cellular networking with PseAAC and molecular fingerprints. J. Theor. Biol 2013, 337C, 71–79.
- Chou, K.C. Some remarks on protein attribute prediction and pseudo amino acid composition (50th Anniversary Year Review). J. Theor. Biol 2011, 273, 236–247.
- Lu, C.T.; Huang, K.Y.; Su, M.G.; Lee, T.Y.; Bretana, N.A.; Chang, W.C.; Chen, Y.J.; Huang, H.D. DbPTM 3.0: An informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res 2013, 41, D295–D305.
- Chou, K.C. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem 1993, 268, 16938–16948.
- Chou, K.C. Review: Prediction of human immunodeficiency virus protease cleavage sites in proteins. Anal. Biochem 1996, 233, 1–14.
- Chou, K.C. A sequence-coupled vector-projection model for predicting the specificity of GalNAc-transferase. Protein Sci 1995, 4, 1365–1383.
- Chou, K.C. Prediction of protein signal sequences and their cleavage sites. Proteins: Struct. Funct. Genet 2001, 42, 136–139.
- Chou, K.C. Using subsite coupling to predict signal peptides. Protein Eng 2001, 14, 75–79.
- Chou, K.C. Prediction of signal peptides using scaled window. Peptides 2001, 22, 1973–1979.
- Chou, K.C. Review: Prediction of protein signal sequences. Curr. Protein Peptide Sci 2002, 3, 615–622.
- Chou, K.C.; Shen, H.B. Review: Recent progresses in protein subcellular location prediction. Anal. Biochem 2007, 370, 1–16.
- Hajisharifi, Z.; Piryaiee, M.; Mohammad Beigi, M.; Behbahani, M.; Mohabatkar, H. Predicting anticancer peptides with Chou’s pseudo amino acid composition and investigating their mutagenicity via Ames test. J. Theor. Biol 2014, 341, 34–40.
- Chen, Y.K.; Li, K.B. Predicting membrane protein types by incorporating protein topology, domains, signal peptides, and physicochemical properties into the general form of Chou’s pseudo amino acid composition. J. Theor. Biol 2013, 318, 1–12.
- Xu, Y.; Ding, J.; Wu, L.Y.; Chou, K.C. iSNO-PseAAC: Predict cysteine S-nitrosylation sites in proteins by incorporating position specific amino acid propensity into pseudo amino acid composition. PLoS One 2013, 8, e55844.
- Xiao, X.; Wang, P.; Lin, W.Z.; Jia, J.H.; Chou, K.C. iAMP-2L: A two-level multi-label classifier for identifying antimicrobial peptides and their functional types. Anal. Biochem 2013, 436, 168–177.
- Mohabatkar, H.; Beigi, M.M.; Abdolahi, K.; Mohsenzadeh, S. Prediction of allergenic proteins by means of the concept of chou’s pseudo amino acid composition and a machine learning approach. Med. Chem 2013, 9, 133–137.
- Xu, Y.; Shao, X.J.; Wu, L.Y.; Deng, N.Y.; Chou, K.C. iSNO-AAPair: Incorporating amino acid pairwise coupling into PseAAC for predicting cysteine S-nitrosylation sites in proteins. PeerJ 2013, 1, e171.
- Chou, K.C. Prediction of protein cellular attributes using pseudo amino acid composition. Proteins: Struct. Funct. Genet 2001, 43, 246–255.
- Chou, K.C. Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes. Bioinformatics 2005, 21, 10–19.
- Du, P.; Wang, X.; Xu, C.; Gao, Y. PseAAC-Builder: A cross-platform stand-alone program for generating various special Chou’s pseudo-amino acid compositions. Anal. Biochem 2012, 425, 117–119.
- Georgiou, D.N.; Karakasidis, T.E.; Megaritis, A.C. A short survey on genetic sequences, Chou’s pseudo amino acid composition and its combination with fuzzy set theory. Open Bioinforma. J 2013, 7, 41–48.
- Liu, B.; Wang, X.; Zou, Q.; Dong, Q.; Chen, Q. Protein remote homology detection by combining Chou’s pseudo amino acid composition and profile-based protein representation. Mol. Inform 2013, 32, 775–782.
- Lin, S.X.; Lapointe, J. Theoretical and experimental biology in one. J. Biomed. Sci. Eng 2013, 6, 435–442.
- Cao, D.S.; Xu, Q.S.; Liang, Y.Z. Propy: A tool to generate various modes of Chou’s PseAAC. Bioinformatics 2013, 29, 960–962.
- Chou, K.C.; Tomasselli, A.L.; Reardon, I.M.; Heinrikson, R.L. Predicting HIV protease cleavage sites in proteins by a discriminant function method. Proteins: Struct. Funct. Genet 1996, 24, 51–72.
- Chen, W.; Lin, H.; Feng, P.M.; Ding, C.; Zuo, Y.C.; Chou, K.C. iNuc-PhysChem: A sequence-based predictor for identifying nucleosomes via physicochemical properties. PLoS One 2012, 7, e47843.
- Chou, K.C.; Shen, H.B. Euk-mPLoc: A fusion classifier for large-scale eukaryotic protein subcellular location prediction by incorporating multiple sites. J. Proteome Res 2007, 6, 1728–1734.
- Chou, K.C.; Wu, Z.C.; Xiao, X. iLoc-Hum: Using accumulation-label scale to predict subcellular locations of human proteins with both single and multiple sites. Mol. Biosyst 2012, 8, 629–641.
- Shen, H.B.; Chou, K.C. Hum-mPLoc: An ensemble classifier for large-scale human protein subcellular location prediction by incorporating samples with multiple sites. Biochem. Biophys. Res. Commun 2007, 355, 1006–1011.
- Chou, K.C. Some Remarks on Predicting Multi-Label Attributes in Molecular Biosystems. Mol. Biosyst 2013, 9, 1092–1100.
- Chou, K.C.; Zhang, C.T. Review: Prediction of protein structural classes. Crit. Rev. Biochem. Mol. Biol 1995, 30, 275–349.
- Chou, K.C.; Shen, H.B. Cell-PLoc: A package of Web servers for predicting subcellular localization of proteins in various organisms. Nat. Protoc 2008, 3, 153–162.
- Chou, K.C.; Shen, H.B. Cell-PLoc 2.0: An improved package of web-servers for predicting subcellular localization of proteins in various organisms. Nat. Sci 2010, 2, 1090–1103.
- Fan, G.L.; Li, Q.Z. Predicting protein submitochondria locations by combining different descriptors into the general form of Chou’s pseudo amino acid composition. Amino Acids 2012, 43, 545–555.
- Fan, G.L.; Li, Q.Z. Discriminating bioluminescent proteins by incorporating average chemical shift and evolutionary information into the general form of Chou’s pseudo amino acid composition. J. Theor. Biol 2013, 334, 45–51.
- Huang, C.; Yuan, J.Q. Predicting protein subchloroplast locations with both single and multiple sites via three different modes of Chou’s pseudo amino acid compositions. J. Theor. Biol 2013, 335, 205–212.
- Lin, H. The modified Mahalanobis discriminant for predicting outer membrane proteins by using Chou’s pseudo amino acid composition. J. Theor. Biol 2008, 252, 350–356.
- Lin, H.; Wang, H.; Ding, H.; Chen, Y.L.; Li, Q.Z. Prediction of Subcellular Localization of Apoptosis Protein Using Chou’s Pseudo Amino Acid Composition. Acta Biotheor 2009, 57, 321–330.
- Qiu, J.D.; Huang, J.H.; Liang, R.P.; Lu, X.Q. Prediction of G-protein-coupled receptor classes based on the concept of Chou’s pseudo amino acid composition: An approach from discrete wavelet transform. Anal. Biochem 2009, 390, 68–73.
- Sahu, S.S.; Panda, G. A novel feature representation method based on Chou’s pseudo amino acid composition for protein structural class prediction. Comput. Biol. Chem 2010, 34, 320–327.
- Sun, X.Y.; Shi, S.P.; Qiu, J.D.; Suo, S.B.; Huang, S.Y.; Liang, R.P. Identifying protein quaternary structural attributes by incorporating physicochemical properties into the general form of Chou’s PseAAC via discrete wavelet transform. Mol. BioSyst 2012, 8, 3178–3184.
- Zeng, Y.H.; Guo, Y.Z.; Xiao, R.Q.; Yang, L.; Yu, L.Z.; Li, M.L. Using the augmented Chou’s pseudo amino acid composition for predicting protein submitochondria locations based on auto covariance approach. J. Theor. Biol 2009, 259, 366–372.
- Zhou, X.B.; Chen, C.; Li, Z.C.; Zou, X.Y. Using Chou’s amphiphilic pseudo-amino acid composition and support vector machine for prediction of enzyme subfamily classes. J. Theor. Biol 2007, 248, 546–551.
- Chou, K.C.; Shen, H.B. Review: Recent advances in developing web-servers for predicting protein attributes. Nat. Sci 2009, 2, 63–92, doi:10.4236/ns.2009.12011.
|Table 1. The jackknife test results by the new predictor on the benchmark datasets in the Supplementary Information S1 and S2. HyP, hydroxyproline; HyL, hydroxylysine; Sn, sensitivity; Sp, specificity; Acc, accuracy; MCC, Matthews correlation coefficient.|
|Benchmark dataset a||Sn (%)||Sp (%)||Acc (%)||MCC|
|Supplementary Information S1 for HyP||80.66||80.54||80.57||0.51|
|Supplementary Information S2 for HyL||87.85||83.01||83.56||0.50|
aNone of the sequences included has more than 80% pairwise sequence identity with any other.
|Table 2. The jackknife test results by the iHyd-PseAAC predictor on the benchmark datasets in Supplementary Information S3 and S4.|
|Benchmark dataset a||Sn (%)||Sp (%)||Acc (%)||MCC|
|Supplementary Information S1 for HyP||70.68||89.03||78.42||0.52|
|Supplementary Information S2 for HyL||79.04||86.37||83.12||0.51|
aNone of sequences included has more than 40% pairwise sequence identity with any other.
|Table 3. The overall success rates in identifying hydroxylated sites for the proteins retrieved from the Swiss-Prot database.|
|Hydroxylated type||Sn (%)||Sp (%)||Acc (%)|
© 2014 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).